- TM Capital advised Surpass Medical, Ltd. in its acquisition by Stryker Corporation (NYSE:SYK) in an all cash transaction for $135 million, $100mm upfront and up to an additional $35 million of milestone payments
- Stryker, a world leader in orthopedic products and medical specialties, has built a global platform in innovative neurovascular devices
- Surpass Medical, based in Tel Aviv, Israel and Miramar, Florida, has developed and commercialized a next-generation flow diversion technology to treat brain aneurysms using a unique mesh design and delivery system
- Surpass’ NeuroEndoGraft product has a CE Mark in Europe and has an accepted IDE to enroll patients in a US pivotal clinical trial
Healthcare
|
Mergers & Acquisitions